CoChat

Higher versus lower blood pressure targets for vasopressor therapy in shock: A multicentre pilot randomized controlled trial.

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Purpose In shock, hypotension may contribute to inadequate oxygen delivery, organ failure and death. We conducted the Optimal Vasopressor Titration (OVATION) pilot trial to inform the design of a larger trial examining the effect of lower versus higher mean arterial pressure (MAP) targets for vasopressor therapy in shock. Methods We randomly assigned critically ill patients who were presumed to suffer from vasodilatory shock regardless of admission diagnosis to a lower (60-65 mmHg) versus a higher (75-80 mmHg) MAP target. The primary objective was to measure the separation in MAP between groups. We also recorded days with protocol deviations, enrolment rate, cardiac arrhythmias and mortality for prespecified subgroups. Results A total of 118 patients were enrolled from 11 centres (2.3 patients/site/month of screening). The between-group separation in MAP was 9 mmHg (95% CI 7-11). In the lower and higher MAP groups, we observed deviations on 12 versus 8% of all days on vasopressors (p = 0.059). Risks of cardiac arrhythmias (20 versus 36%, p = 0.07) and hospital mortality (30 versus 33%, p = 0.84) were not different between lower and higher MAP arms. Among patients aged 75 years or older, a lower MAP target was associated with reduced hospital mortality (13 versus 60%, p = 0.03) but not in younger patients. Conclusions This pilot study supports the feasibility of a large trial comparing lower versus higher MAP targets for shock. Further research may help delineate the reasons f…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00134-016-4237-3

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 236

Metadata

Authors
for the Canadian Critical Care Trials Group., Lamontagne, F., Meade, M. O., Hébert, P. C., Asfar, P., Lauzier, F., Seely, A. J. E., Day, A. G., Mehta, S., Muscedere, J., Bagshaw, S. M., Ferguson, N. D., Cook, D. J., Kanji, S., Turgeon, A. F., Herridge, M. S., Subramanian, S., Lacroix, J., Adhikari, N. K. J., Scales, D. C., Fox-Robichaud, A., Skrobik, Y., Whitlock, R. P., Green, R. S., Koo, K. K. Y., Tanguay, T., Magder, S., & Heyland, D. K.
Affiliations
  • Université de Sherbrooke (CA)
  • Université de Montréal (CA)
  • Université d'Angers (FR)
  • Université Laval (CA)
  • University of Ottawa (CA)
  • University of Toronto (CA)
  • University of Alberta (CA)
  • Ottawa Hospital Research Institute (CA)
  • Centre Hospitalier Universitaire Sainte-Justine (CA)
  • Sunnybrook Health Science Centre (CA)
  • McGill University (CA)
  • Dalhousie University (CA)
  • Swedish Medical Center (US)
  • Kingston General Hospital (CA)
Corresponding author
Lamontagne, François
Venue
Intensive Care Medicine
Published
2016-02-18
Volume
42
Issue
4
Pages
542-550
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W2287296216
Cited by
230
References
22
Citations by year
2026: 16 · 2025: 28 · 2024: 29 · 2023: 33 · 2022: 21 · 2021: 25 · 2020: 20 · 2019: 22 · 2018: 14 · 2017: 15 · 2016: 7
FWCI
21.40
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Intensive Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Institute of Circulatory and Respiratory Health (126066)
  • Fonds de Recherche du Québec - Santé (CA) (27102)
Topics
  • Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords
vasopressor therapy, vasodilatory shock, mean arterial pressure targets, hypotension, vasopressor titration, cardiac arrhythmias, in-hospital mortality, critically ill patients, older adults, trial feasibility
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Hypotension, Male, Middle Aged, Pilot Projects, Shock, Vasoconstrictor Agents, Arterial Pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.